a Canadian vertically-integrated biopharmaceutical company

Developing and commercializing various cannabinoid-based products for the global market place

Sponsored
Message: VIDEO - Avicanna (AVCN:TSX) Is Delivering The Vertically Integrated Cannabis Company That Others Failed To

VIDEO - Avicanna (AVCN:TSX) Is Delivering The Vertically Integrated Cannabis Company That Others Failed To

posted on Sep 07, 2020 08:57PM

The Tortoise and the Hare is the famous fable most of us grew up with that teaches this very important lesson - you can be more successful by doing things slowly and steadily than by acting quickly and carelessly.  Said another way, slow and steady wins the race. 

Avicanna (AVCN:TSX) (AVCNF:OTCQB) (0NN:Frankfurt) is the Hare.  The company very few paid attention to because it started off the Cannabis stock market race slowly and surely, while all the other rabbits ran so quickly to win the race that they ended up tripping over themselves or getting so exhausted they couldn't finish the race. 

You know who those companies are.  All flash, big promises, big promotions, big stock prices ..... and HUGE disappointments. 

Avicanna has surpassed all of them and is starting to pick up speed.  When Avicanna says it is vertically integrated, it isn't a buzz word, it's the real story with 4 fully operating divisions that are hitting on all cylinders including, Tier-1 National Partnerships, Global Distribution, Medical Acceptance and History Making Sales. 

Here is a snapshot of what we are referring to, followed by an incredible interview with CEO, Aras Azadian, whose quiet confidence sends the following powerful message -  

"Watch Us Cross The Finish Line" 

CONSUMER RETAIL - COSMETICS 

  • The Only Known CBD Cosmetics Backed By Clinical Trials
  • Full Line Of High End CBD Based Skin Care Products
  • Already Commercializing In Colombia
  • Global Distribution In H2 2020 In United States, Europe and Canada
    • Canadian Distribution Through Shoppers Drug Mart

MEDICAL CANNABIS

  • Medical Cannabis 2.0 – Superior Products To Products Currently On The Market
    • Evidence Backed Medical Cannabis So Doctors Can Prescribe With Confidence
  • Successfully launched advanced products under RHO Phyto™ brand nation-wide in Canada through Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart
  • Global Distribution Through US, U.K, Australia, Colombia in H2 2020

      PHARMACEUTICALS

  • A Full Pipeline Of Pharmaceuticals In Various Stages Of Trials To Address Dermatology, Psychiatry, Neurology, Pain and Oncology
  • 3 Products Already As Far As PHASE 2

      CULTIVATION

  • 500,000 Sq Ft Of Low Cost and USDA certified Organic Cannabis Cultivation In ColombiaFirst Ever Export Of Feminized Hemp Seeds From Colombia (To United States).
  • 7,000,000 Seeds For $380,000Additional 75,000,000 Seeds Available For Export In Several Pending Transactions 

Q2 HIGHLIGHTS

  • Revenue increased 172% from $260,903 in Q1 2020 to $709,468 in Q2 2020, and a substantial increase from $16,571 in Q2 2019, coupled with 8% cost reduction from Q1 2020, and 31% cost reduction from Q2 2019

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

 

Share
New Message
Please login to post a reply